Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Deferred Taxes (2025 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) reported Deferred Taxes of -$3,000 for Q2 2026, compared with $638,000 a year earlier.

Analysis

Recursion Pharmaceuticals (RXRX) Deferred Taxes (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Recursion Pharmaceuticals' Deferred Taxes came in at -$4.38 million.

  • Five-year quarterly Deferred Taxes spans a low of -$4.6 million in Q1 2026 and a high of $638,000 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -479.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -195.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn -3,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,000.00
Mar 31, 2026 -4.60 Mn
Jun 30, 2025 638,000.00
Mar 31, 2025 -419,000.00
API Access

Recursion Pharmaceuticals Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=RXRX&period=max&api_key=YOUR_API_KEY